Clinical Trials

Colonic Neoplasms

NCT05291156 2024-02-01

CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy

173 enrolled

Colorectal Neoplasms

NCT06101394 2024-01-25

RECOGNISE

25 enrolled

Thoracic

Lung Neoplasms

NCT06107114 2023-11-22

CZCNRHNSCC

52 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT00997009 2023-11-14

MITO CERV 2

108 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04034459 2023-11-14

AIO-KRK-0116

109 enrolled

Colorectal Neoplasms

NCT02624128 2023-11-13

V-CHANCE

39 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT06118047 2023-11-07

COSTIC

33 enrolled

Colorectal Neoplasms

NCT06081582 2023-10-13

Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC

33 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04984369 2023-08-21

The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line Treatment

CRC

NCT04262635 2023-08-02

C-CLASSIC

80 enrolled

Colorectal Neoplasms

NCT03284502 2023-08-01

HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors

148 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT04189055 2023-06-12

CETIDYL

72 enrolled

Colonic Neoplasms

NCT05160896 2023-06-08

SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer

90 enrolled

Advanced Metastatic Colorectal Cancer

NCT03391934 2023-04-05

Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer

234 enrolled

Colorectal Neoplasms

NCT05799443 2023-04-05

Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal Cancer

23 enrolled

Colorectal Neoplasms

NCT05745857 2023-02-27

SLURP

25 enrolled

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT04359199 2023-02-10

QUASAR

Unknown

42 enrolled

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT05684211 2023-02-01

A Study of Ametumumab in Combination With Anti-PD-1 Monoclonal Antibody and FOLFIRI in Patients With RAS Wild-type Advanced Colorectal Cancer

84 enrolled

Colorectal Neoplasms

NCT01855451 2022-11-18

HPVOropharynx

189 enrolled

Tumor-Agnostic

Carcinoma

NCT05497336 2022-09-30

A Study of IBI351 in Combination With Cetuximab in Subjects With KRAS G12C Mutated Metastatic Colorectal Cancer

80 enrolled

Colorectal Neoplasms

NCT05155124 2022-09-13

Safety of Cetuximab and Trifluridin Tipiracil as the Third-line Therapy in the RASwt mCRC

6 enrolled

Colonic Neoplasms

NCT05019534 2022-05-19

Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer

12 enrolled

BRAF V600E-mutated /MSS Metastatic Colorectal Cancer

NCT03457896 2022-03-31

Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status

35 enrolled

Colorectal Neoplasms

NCT02675946 2022-01-26

CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

72 enrolled

Gastrointestinal Neoplasms

NCT05103020 2021-11-02

Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases

100 enrolled

Colorectal Neoplasms

NCT05074966 2021-10-12

The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts

314 enrolled

Colonic Neoplasms

NCT02826837 2021-10-06

LEAC-102 for Advanced Colorectal Cancer

Phase 1/2 Unknown

30 enrolled

Advanced Colorectal Cancer

NCT04241731 2021-08-30

A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal Cancer

Colorectal Neoplasms

NCT04466254 2021-08-23

Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer

75 enrolled

Colorectal Neoplasms

NCT03727763 2021-08-19

Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT)

30 enrolled

Colorectal Neoplasms

NCT04872634 2021-07-21

SNK_ASTER

Phase 1/2 Unknown

24 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03552406 2021-05-06

Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors

33 enrolled

BreastHead & Neck

Breast Neoplasms, Head and Neck Neoplasms

NCT02942706 2021-04-30

Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC

Phase 2/3 Unknown

200 enrolled

Colorectal Neoplasms

NCT04832776 2021-04-06

FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases

160 enrolled

Liver Metastasis Colon Cancer

NCT04833036 2021-04-06

c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRI

120 enrolled

Colorectal Neoplasms

NCT02054442 2021-03-12

COMMENCE

Phase 1/2 Unknown

52 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04668976 2020-12-21

A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

100 enrolled

Colorectal Neoplasms, Cholangiocarcinoma

NCT03608046 2020-10-22

AVETUXIRI

59 enrolled

Colonic Neoplasms

NCT04525326 2020-08-25

Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases

584 enrolled

Colorectal Neoplasms

NCT04509635 2020-08-12

Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis

Colorectal Neoplasms

NCT02123381 2020-03-17

Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

100 enrolled

Esophageal Squamous Cell Carcinoma, Neoplasms

NCT03491709 2019-10-31

A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC

18 enrolled

Colorectal Neoplasms

NCT01923987 2019-09-20

Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis

39 enrolled

Rectal Neoplasms

NCT01802645 2019-09-11

CELIM2

91 enrolled

Colorectal Neoplasms

NCT03944252 2019-07-26

CARACAS

54 enrolled

Anus Neoplasms

NCT03923036 2019-04-22

AVOCETTE

Unknown

2,000 enrolled

Colorectal Cancer Metastatic

NCT02636088 2018-09-21

LERFOX-C

51 enrolled

Esophageal Neoplasms

NCT03356158 2018-09-17

A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer

21 enrolled

Colorectal Neoplasms

NCT03666325 2018-09-11

I-Tackle